Literature DB >> 1620827

Gadolinium-enhanced magnitude contrast MR angiography of popliteal and tibial arteries.

S V Lossef1, S S Rajan, R H Patt, M Carvlin, D Calcagno, M N Gomes, K H Barth.   

Abstract

To evaluate the efficacy of gadopentetate dimeglumine in MR angiography of the lower extremities, a flow phantom, seven healthy volunteers, and seven patients with peripheral vascular disease were studied with a magnitude contrast (MC) technique. The combination of an MC rephase-dephase gradient-refocused-echo pulse sequence, a 40-cm-long transmit-receive coil, and intravenous administration of a bolus of gadopentetate dimeglumine improved MR angiographic quality in the phantom, volunteers, and patients. Gadolinium enhancement decreased deleterious saturation effects and improved images of the popliteal and tibioperoneal arteries in the volunteers and patients. However, in some cases, venous overlap, imaging artifacts, and suboptimal visualization of subtle lesions limited interpretation. The authors conclude that gadolinium enhancement combined with an MC subtraction pulse sequence appreciably improves MR angiography of lower extremity arteries.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620827     DOI: 10.1148/radiology.184.2.1620827

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  3 in total

1.  The optimization of scan timing for contrast-enhanced magnetic resonance angiography.

Authors:  J J Lee; P J Tirman; Y Chang; H K Ryeom; S K Lee; Y S Kim; D S Kang
Journal:  Korean J Radiol       Date:  2000 Jul-Sep       Impact factor: 3.500

2.  Contrast-enhanced magnetic resonance angiography: dose the test dose bolus represent the main dose bolus accurately?

Authors:  J J Lee; Y Chang; D S Kang
Journal:  Korean J Radiol       Date:  2000 Apr-Jun       Impact factor: 3.500

3.  Real-time catheter-directed MRA with effective background suppression and persistent rendering.

Authors:  Michael A Guttman; Amish N Raval; Robert J Lederman; Elliot R McVeigh
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.